These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1058840)

  • 21. Lymphocyte response to autologous tumor antigen(s) and phytohemagglutinin in ovarian cancer patients.
    Chatterjee M; Barlow JJ; Allen HJ; Chung WS; Piver MS
    Cancer; 1975 Sep; 36(3):956-62. PubMed ID: 1182682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro "education" on autologous human sarcoma generates non-specific killer cells.
    Martin-Chandon MR; Vanky F; Carnaud C; Klein E
    Int J Cancer; 1975 Feb; 15(2):342-50. PubMed ID: 1055101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific antigen stimulated lymphocyte proliferation in osteosarcoma.
    Gainor BJ; Forbes JT; Enneking WF; Smith RT
    Cancer; 1976 Feb; 37(2):743-50. PubMed ID: 1062227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative analysis of immunoreactive indices in malignant and benign bone tumors].
    Govallo VI; Grigor'eva MP; Kosmiadi GA; Zatsepin ST
    Vopr Onkol; 1984; 30(10):19-25. PubMed ID: 6093380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A micro-method for PHA-induced stimulation of human lymphocytes. I. Communication: Technical considerations (author's transl)].
    Pees H; Pappas A
    Z Immunitatsforsch Exp Klin Immunol; 1975 Oct; 150(4):309-17. PubMed ID: 129974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular immunity to a common human sarcoma antigen and its specific inhibition by sera from patients with growing sarcomas.
    Cohen AM; Ketcham AS; Morton DL
    Surgery; 1972 Oct; 72(4):560-7. PubMed ID: 4506654
    [No Abstract]   [Full Text] [Related]  

  • 27. [Decrease of mitogen stimulation of lymphocytes in rheumatoid arthritis].
    Genth E; Kurze R; Nowak H; Franz K; Brude E; Hartl W
    Z Rheumatol; 1977; 36(5-6):168-79. PubMed ID: 899297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lysis of tumor biopsy cells by autologous T lymphocytes activated in mixed cultures and propagated with T cell growth factor.
    Vánky F; Gorsky T; Gorsky Y; Masucci MG; Klein E
    J Exp Med; 1982 Jan; 155(1):83-95. PubMed ID: 6459402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase I study of the adoptive immunotherapy of human cancer with lectin activated autologous mononuclear cells.
    Mazumder A; Eberlein TJ; Grimm EA; Wilson DJ; Keenan AM; Aamodt R; Rosenberg SA
    Cancer; 1984 Feb; 53(4):896-905. PubMed ID: 6692292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Capacity of sera from patients with primary intracranial tumors to support mitogen stimulation of blood lymphocytes. Correlation to histological tumor type.
    Blomgren H; Blom U; Ullén H
    Anticancer Res; 1985; 5(4):349-54. PubMed ID: 4037733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
    Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
    J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. sCD30 and sCD40L detection in patients with osteosarcoma, chondrosarcoma and Ewing sarcoma.
    Solooki S; Khozaei A; Shamsdin SA; Emami MJ; Khademolhosseini F
    Iran J Immunol; 2013 Dec; 10(4):229-37. PubMed ID: 24375064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transformation antigens on stimulated lymphocytes.
    Bluming AZ; Lynch MJ; Kavanah M; Khiroya R
    J Immunol; 1975 Feb; 114(2 pt 2):717-21. PubMed ID: 1112977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lysis of autologous tumor cells by blood lymphocytes tested at the time of surgery. Correlation with the postsurgical clinical course.
    Vánky F; Klein E; Willems J; Böök K; Ivert T; Péterffy A; Nilsonne U; Kreicbergs A; Aparisi T
    Cancer Immunol Immunother; 1986; 21(1):69-76. PubMed ID: 3455878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mixed lymphocyte--tumor cell culture reaction in cancer patients.
    Ikeda H; Toge T; Niimoto M; Hattori T
    Gan; 1978 Jun; 69(3):417-21. PubMed ID: 149686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impaired lymphocyte responsiveness in osteosarcoma.
    Twomey PL; Chretien PB
    J Surg Res; 1975 May; 18(5):551-4. PubMed ID: 1055278
    [No Abstract]   [Full Text] [Related]  

  • 37. Proliferation of peripheral lymphocytes to interleukin-2 and interleukin-4 after marrow transplantation.
    Klingemann HG; Kohn FR; Phillips GL
    Eur Cytokine Netw; 1991; 2(2):131-6. PubMed ID: 1813016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specificity of auto-tumor cytotoxicity exerted by fresh, activated and propagated human T lymphocytes.
    Vánky F; Klein E
    Int J Cancer; 1982 May; 29(5):547-53. PubMed ID: 6178704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stimulation of allogeneic and autologous MLR by subpopulations of human monocytes.
    Uren S; Boyle W
    Transplant Proc; 1989 Feb; 21(1 Pt 1):208-10. PubMed ID: 2523125
    [No Abstract]   [Full Text] [Related]  

  • 40. [Evaluation of the immunological status of patients with cerebral neoplasms].
    Perria C; Di Benedetto G; Barabino A; Soldà AM; Indiveri F
    Boll Soc Ital Biol Sper; 1974 Nov; 50(22):1930-5. PubMed ID: 4376965
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.